Laurence Reid

Laurence Reid serves as the Chief Executive Officer of Decibel Therapeutics since January 2020 and has held the role of Acting Chief Executive Officer in addition to being a Member of the Board of Directors at Garuda Therapeutics since January 2022. Previously, Laurence was the Entrepreneur In Residence at Third Rock Ventures from December 2019 to November 2020 and the Chief Executive Officer of Warp Drive Bio, LLC from March 2015 to October 2018, where significant advancements in drugging KRAS were achieved. Earlier experience includes leadership positions as Chief Business Officer at Alnylam Pharmaceuticals and Ensemble Discovery Corporation, and General Manager at Millennium Pharmaceuticals. Educational credentials include a BA in Natural Sciences from the University of Cambridge, a Ph.D. in Biochemistry from the University of London, and ongoing studies at the Massachusetts Institute of Technology and The Wharton School in relevant business and management programs.